Statera Biopharma, Inc. Increase (Decrease) in Derivative Liabilities
Statera Biopharma, Inc. reported Increase (Decrease) in Derivative Liabilities of $3.45 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2013-05-09
- Statera Biopharma, Inc. increase (decrease) in derivative liabilities for the quarter ending 2013-03-31 was $3.45M.
- Statera Biopharma, Inc. increase (decrease) in derivative liabilities for the quarter ending 2012-12-31 was -$7.86M, a 717.82% decline year-over-year.
- Statera Biopharma, Inc. increase (decrease) in derivative liabilities for the quarter ending 2012-09-30 was $4.42M.
- Statera Biopharma, Inc. increase (decrease) in derivative liabilities for the quarter ending 2012-06-30 was -$2.54M.
- Statera Biopharma, Inc. increase (decrease) in derivative liabilities for fiscal 2012 was -$7.70M.
- Statera Biopharma, Inc. increase (decrease) in derivative liabilities for fiscal 2011 was -$19.82M, a 223.80% decline from fiscal 2010.
- Statera Biopharma, Inc. increase (decrease) in derivative liabilities for fiscal 2010 was $16.01M.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2013-03-31 | $3.45M 10-Q · filed 2013-05-09 | -$4.42M derived: sum of 2 quarters · filed 2013-05-09 | $8.77K derived: sum of 3 quarters · filed 2013-05-09 | -$2.53M derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-12-31 | -$7.86M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$3.44M derived: sum of 2 quarters · filed 2013-03-18 | -$5.98M derived: sum of 3 quarters · filed 2013-03-18 | -$7.70M 10-K · filed 2013-03-18 |
| 2012-09-30 | $4.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $1.88M derived: sum of 2 quarters · filed 2012-11-09 | $160.75K 10-Q · filed 2012-11-09 | $1.43M derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-06-30 | -$2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$4.26M 10-Q · filed 2012-08-09 | -$2.99M derived: sum of 3 quarters · filed 2013-05-09 | -$6.98M derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-03-31 | -$1.72M 10-Q · filed 2013-05-09 | -$447.09K derived: sum of 2 quarters · filed 2013-05-09 | -$4.44M derived: sum of 3 quarters · filed 2013-05-09 | -$22.26M derived: sum of 4 quarters · filed 2013-05-09 |
| 2011-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$2.72M derived: sum of 2 quarters · filed 2013-03-18 | -$20.54M derived: sum of 3 quarters · filed 2013-03-18 | -$19.82M 10-K · filed 2013-03-18 |
| 2011-09-30 | -$3.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$21.81M derived: sum of 2 quarters · filed 2012-11-09 | -$21.09M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | -$17.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$17.10M 10-Q · filed 2012-08-09 | ||
| 2011-03-31 | $714.95K 10-Q · filed 2012-05-07 | |||
| 2010-12-31 | $16.01M 10-K · filed 2013-03-18 |